|
|
|
|
|
|
|
|
abstract
ep·i·tope
(ĕp′ĭ-tōp′)n. A localized region on the surface of an antigen capable of eliciting an immune response and of combining with a specific antibody to counter that response.Purpose
Mutations in TP53
induce autoantibody immune responses in a subset of cancer patients,
which have been proposed as biomarkers for early detection. Here, we
investigate the association of p53 specific autoantibodies with multiple
tumor subtypes and determine the association with p53 mutation status
and epitope specificity.
Experimental Design
IgG
p53 autoantibodies (p53-AAb), were quantified in 412 serum samples
using a programmable ELISA assay from patients with serous ovarian,
pancreatic adenocarcinoma, and breast cancer. To determine if patients
generated mutation specific autoantibodies we designed a panel of the
most relevant 51 p53 point mutant proteins....
Results
We
detected p53-AAb with sensitivities of 58.8% (ovarian), 22%
(pancreatic), 32% (triple negative breast cancer), and 10.2% (HER2+
breast cancer) at 94% specificity. Sera with p53-AAb contained
broadly-reactive autoantibodies to 51 displayed p53 mutant proteins,
demonstrating a polyclonal response to common epitopes. All p53-AAb
displayed broad polyclonal immune response to both continuous and
discontinuous epitopes at the N- and C-terminus as well as the DNA
binding domain.
Conclusion and clinical relevance
In
this comprehensive analysis, mutations in tumor p53 induce strong,
polyclonal autoantibodies with broadly reactive epitope specificity.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.